elderly patients are an unmet need in hodgkin lymphoma
Published 3 years ago • 150 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
4:18
pembrolizumab monotherapy for older/abvd-ineligible patients with hodgkin lymphoma
-
2:52
elderly patients with hl: unmet needs and promising strategies
-
2:30
optimal management of hodgkin lymphoma in elderly patients and those with comorbidities
-
2:03
unmet needs in lbcl: treatment options for elderly or frail patients
-
1:30
recent updates in hl research & the importance of improving treatment for elderly & frail patients
-
9:25
mgus diagnosis: a step-by-step approach
-
3:03
how bad is lymphoma cancer?
-
4:51
the current frontline treatment strategy in multiple myeloma
-
1:03
geriatric oncology: immunotherapy for elderly patients with lymphoma
-
1:23
defining elderly patients in the context of dlbcl treatment
-
1:58
outcomes of patients with hodgkin lymphoma undergoing allohsct after pembrolizumab therapy
-
3:49
the patient burden of illness and unmet needs in scd & highlights from eha 2024
-
1:10
avenue: avelumab for classical hodgkin lymphoma
-
1:25
a-hipi, a novel prognostic model for advanced hl & outcomes of elderly patients with hl in australia
-
1:33
why are elderly patients underrepresented in myeloma clinical trials?
-
1:37
the role of ctdna in hodgkin lymphoma
-
1:51
unmet needs in follicular lymphoma
-
1:27
classifying frailty in patients with hodgkin lymphoma
-
1:32
management and outcomes of elderly patients with lbcl
-
0:51
treating patients with hodgkin lymphoma who are chemo-resistant
-
5:46
the use of allogeneic transplantation in the era of checkpoint blockade therapy in hodgkin lymphoma